Focus on Uterine Fibroids: Evolving Options to Optimize Care

Live Symposium

Monday, May 8, 2017

6:00 AM – 6:15 AM   Breakfast and On-site Check-in
6:15 AM – 7:45 AM   CME Forum

San Diego Convention Center
Room: 17AB, Mezzanine Level
San Diego, California

FACULTY

Sukhbir Sony Singh, MD, FRCSC, FACOG (Program Chair)
Associate Professor and Vice-Chair of Gynecology
Department of Obstetrics and Gynecology
The Ottawa Hospital
University of Ottawa
Ottawa, Ontario, Canada

Erica E. Marsh, MD, MSCI, FACOG
Associate Professor and Chief
Division of Reproductive Endocrinology and Infertility
Department of Obstetrics and Gynecology
University of Michigan Health System
University of Michigan
Ann Arbor, Michigan

PROGRAM OVERVIEW

Uterine fibroids, the most common benign pelvic tumors, affect nearly 70% of white women and more than 80% of African American women in the United States by the age of 50 years. They cause significant morbidity, as up to 50% of women with fibroids experience symptoms, including heavy menstrual bleeding, dysmenorrhea, and reproductive dysfunction. The current mainstay of management is surgical: uterine fibroids account for approximately one-third of all hysterectomies annually in the United States. Until recently, medical management options have been of limited value because of moderate efficacy and/or associated adverse effects. Novel therapies in late-stage development, including oral treatments, may offer better long-term medical management options.

AGENDA

6:00 AM – 6:15 AM: Breakfast and On-site Check-in

6:15 AM – 6:30 AM: Welcome and Introduction
Sukhbir Sony Singh, MD, FRCSC, FACOG

6:30 AM – 6:55 AM: The Landscape of Uterine Fibroids: What Do We Know? What Do We Need? What Do Our Patients Need?
Erica E. Marsh, MD, MSCI, FACOG

6:55 AM – 7:30 AM: Expanding Medical Treatment Options for Uterine Fibroids
Sukhbir Sony Singh, MD, FRCSC, FACOG

Interactive Case Studies
Sukhbir Sony Singh, MD, FRCSC, FACOG
Erica E. Marsh, MD, MSCI, FACOG

7:30 AM – 7:45 AM   Q&A

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to do the following:

  1. Cite the risk factors for and symptoms of uterine fibroids
  2. Develop a treatment plan for symptomatic uterine fibroids based on benefits and limitations of available therapies
  3. Describe uterine fibroid treatment options in late-stage development
  4. Employ a strong patient-provider collaborative approach designed to engage patients in discussion about uterine fibroid symptoms and treatments

CME CREDIT (PHYSICIAN)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and Miller Medical Communications, LLC. The Elsevier Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment, or management of patients with uterine fibroids.

FEE INFORMATION

There is no fee for this educational activity.

CME INQUIRIES AND SPECIAL NEEDS 

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Miller Medical Communications, LLC, prior to the live event at Kerri.Leonard@millermeded.com, 212-661-7400, ext. 9.

FINANCIAL SUPPORT 

This live activity is supported by an independent educational grant from Allergan Inc.

PARTNER INFORMATION

Jointly provided by the Elsevier Office of Continuing Medical Education and Miller Medical Communications, LLC.

This event is neither sponsored nor endorsed by The American College of Obstetricians and Gynecologists (ACOG).

EVENT DATE:

Monday, May 8, 2017, 6:00 – 7:45 AM

LOCATION:

San Diego Convention Center
Room: 17AB, Mezzanine Level
111 W. Harbor Drive
San Diego, California

You will receive an email confirmation within 1 business day after you complete the registration.

If you are unable to register online or do not receive your confirmation email after registering (don't forget to check your spam email folder), please email Kerri.Leonard@millermeded.com.

Live Symposium
Group visibility: 
Public - accessible to all site users